PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA

Today's Daily Dose brings you news about Prothena pulling the plug on its AL amyloidosis drug candidate NEOD001; FDA panel thumbs up for lower dose of Baricitinib; imposition of FDA's partial hold on Epizyme's Tazemetostat program and FDA striking down Pfizer's Herceptin biosimilar.

from RTT - Biotech https://ift.tt/2JlH75A
via IFTTT